Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 148 entries
Sorted by: Best Match Show Resources per page
[The Health University in Ostergötland. Planning and realization of medical education].

Lakartidningen

Bergdahl B, Koch M, Ludvigsson J, Wessman J.
PMID: 2370806
Lakartidningen. 1990 Jul 11;87(28):2317-21.

No abstract available.

Cite
Bergdahl B, Koch M, Ludvigsson J, et al. Hälsouniversitetet i Ostergötland. Planering och genomförande av läkarutbildningen. [The Health University in Ostergötland. Planning and realization of medical education]. Lakartidningen. 1990;87(28):2317-21
Bergdahl, B., Koch, M., Ludvigsson, J., & Wessman, J. (1990). Hälsouniversitetet i Ostergötland. Planering och genomförande av läkarutbildningen. [The Health University in Ostergötland. Planning and realization of medical education]. Lakartidningen, 87(28), 2317-21.
Bergdahl, B, et al. "Hälsouniversitetet i Ostergötland. Planering och genomförande av läkarutbildningen." [The Health University in Ostergötland. Planning and realization of medical education]. Lakartidningen vol. 87,28 (1990): 2317-21.
Bergdahl B, Koch M, Ludvigsson J, Wessman J. Hälsouniversitetet i Ostergötland. Planering och genomförande av läkarutbildningen. [The Health University in Ostergötland. Planning and realization of medical education]. Lakartidningen. 1990 Jul 11;87(28):2317-21. Swedish. PMID: 2370806.
Copy Download .nbib Format: NLM
Crystallization of methyl ammonium lead halide perovskites: implications for photovoltaic applications.

Journal of the American Chemical Society

Tidhar Y, Edri E, Weissman H, Zohar D, Hodes G, Cahen D, Rybtchinski B, Kirmayer S.
PMID: 25171634
J Am Chem Soc. 2014 Sep 24;136(38):13249-56. doi: 10.1021/ja505556s. Epub 2014 Sep 16.

Hybrid organic/lead halide perovskites are promising materials for solar cell fabrication, resulting in efficiencies up to 18%. The most commonly studied perovskites are CH3NH3PbI3 and CH3NH3PbI3-xClx where x is small. Importantly, in the latter system, the presence of chloride...

Cite
Tidhar Y, Edri E, Weissman H, et al. Crystallization of methyl ammonium lead halide perovskites: implications for photovoltaic applications. J Am Chem Soc. 2014;136(38):13249-56doi: 10.1021/ja505556s.
Tidhar, Y., Edri, E., Weissman, H., Zohar, D., Hodes, G., Cahen, D., Rybtchinski, B., & Kirmayer, S. (2014). Crystallization of methyl ammonium lead halide perovskites: implications for photovoltaic applications. Journal of the American Chemical Society, 136(38), 13249-56. https://doi.org/10.1021/ja505556s
Tidhar, Yaron, et al. "Crystallization of methyl ammonium lead halide perovskites: implications for photovoltaic applications." Journal of the American Chemical Society vol. 136,38 (2014): 13249-56. doi: https://doi.org/10.1021/ja505556s
Tidhar Y, Edri E, Weissman H, Zohar D, Hodes G, Cahen D, Rybtchinski B, Kirmayer S. Crystallization of methyl ammonium lead halide perovskites: implications for photovoltaic applications. J Am Chem Soc. 2014 Sep 24;136(38):13249-56. doi: 10.1021/ja505556s. Epub 2014 Sep 16. PMID: 25171634.
Copy Download .nbib Format: NLM
ReoPro Clinical Development: Future Directions and Therapeutic Approaches.

The Journal of invasive cardiology

Weisman HF.
PMID: 10785772
J Invasive Cardiol. 1996;8:51B-61B.

No abstract available.

Cite
Weisman HF. ReoPro Clinical Development: Future Directions and Therapeutic Approaches. J Invasive Cardiol. 1996;8:51B-61B
Weisman, H. F. (1996). ReoPro Clinical Development: Future Directions and Therapeutic Approaches. The Journal of invasive cardiology, 851B-61B.
Weisman. "ReoPro Clinical Development: Future Directions and Therapeutic Approaches." The Journal of invasive cardiology vol. 8 (1996): 51B-61B.
Weisman HF. ReoPro Clinical Development: Future Directions and Therapeutic Approaches. J Invasive Cardiol. 1996;8:51B-61B. PMID: 10785772.
Copy Download .nbib Format: NLM
Myocardial Reperfusion Injury: The Case Against Shadow Boxing.

Journal of thrombosis and thrombolysis

Weisman HF.
PMID: 10639251
J Thromb Thrombolysis. 1997 Jan;4(1):133-135. doi: 10.1023/a:1017560231064.

No abstract available.

Cite
Weisman HF. Myocardial Reperfusion Injury: The Case Against Shadow Boxing. J Thromb Thrombolysis. 1997;4(1):133-135doi: 10.1023/a:1017560231064.
Weisman, H. F. (1997). Myocardial Reperfusion Injury: The Case Against Shadow Boxing. Journal of thrombosis and thrombolysis, 4(1), 133-135. https://doi.org/10.1023/a:1017560231064
Weisman. "Myocardial Reperfusion Injury: The Case Against Shadow Boxing." Journal of thrombosis and thrombolysis vol. 4,1 (1997): 133-135. doi: https://doi.org/10.1023/a:1017560231064
Weisman HF. Myocardial Reperfusion Injury: The Case Against Shadow Boxing. J Thromb Thrombolysis. 1997 Jan;4(1):133-135. doi: 10.1023/a:1017560231064. PMID: 10639251.
Copy Download .nbib Format: NLM
Clinical use of a carbohydrate-restricted diet to treat the dyslipidemia of the metabolic syndrome.

Metabolic syndrome and related disorders

Hickey JT, Hickey L, Yancy WS, Hepburn J, Westman EC.
PMID: 18370666
Metab Syndr Relat Disord. 2003 Sep;1(3):227-32. doi: 10.1089/154041903322716705.

BACKGROUND: The metabolic syndrome is characterized by an atherogenic dyslipidemia identifiable using lipoprotein subclass analysis. This study assesses the effect of a carbohydrate-restricted diet on the dyslipidemia of the metabolic syndrome in a clinical setting.METHODS: This is a retrospective...

Cite
Hickey JT, Hickey L, Yancy WS, et al. Clinical use of a carbohydrate-restricted diet to treat the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord. 2003;1(3):227-32doi: 10.1089/154041903322716705.
Hickey, J. T., Hickey, L., Yancy, W. S., Hepburn, J., & Westman, E. C. (2003). Clinical use of a carbohydrate-restricted diet to treat the dyslipidemia of the metabolic syndrome. Metabolic syndrome and related disorders, 1(3), 227-32. https://doi.org/10.1089/154041903322716705
Hickey, Joseph T, et al. "Clinical use of a carbohydrate-restricted diet to treat the dyslipidemia of the metabolic syndrome." Metabolic syndrome and related disorders vol. 1,3 (2003): 227-32. doi: https://doi.org/10.1089/154041903322716705
Hickey JT, Hickey L, Yancy WS, Hepburn J, Westman EC. Clinical use of a carbohydrate-restricted diet to treat the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord. 2003 Sep;1(3):227-32. doi: 10.1089/154041903322716705. PMID: 18370666.
Copy Download .nbib Format: NLM
A pilot trial of a low-carbohydrate, ketogenic diet in patients with type 2 diabetes.

Metabolic syndrome and related disorders

Yancy WS, Vernon MC, Westman EC.
PMID: 18370668
Metab Syndr Relat Disord. 2003 Sep;1(3):239-43. doi: 10.1089/154041903322716723.

No abstract available.

Cite
Yancy WS, Vernon MC, Westman EC. A pilot trial of a low-carbohydrate, ketogenic diet in patients with type 2 diabetes. Metab Syndr Relat Disord. 2003;1(3):239-43doi: 10.1089/154041903322716723.
Yancy, W. S., Vernon, M. C., & Westman, E. C. (2003). A pilot trial of a low-carbohydrate, ketogenic diet in patients with type 2 diabetes. Metabolic syndrome and related disorders, 1(3), 239-43. https://doi.org/10.1089/154041903322716723
Yancy, William S, et al. "A pilot trial of a low-carbohydrate, ketogenic diet in patients with type 2 diabetes." Metabolic syndrome and related disorders vol. 1,3 (2003): 239-43. doi: https://doi.org/10.1089/154041903322716723
Yancy WS, Vernon MC, Westman EC. A pilot trial of a low-carbohydrate, ketogenic diet in patients with type 2 diabetes. Metab Syndr Relat Disord. 2003 Sep;1(3):239-43. doi: 10.1089/154041903322716723. PMID: 18370668.
Copy Download .nbib Format: NLM
A low-carbohydrate, ketogenic diet to treat type 2 diabetes.

Nutrition & metabolism

Yancy WS, Foy M, Chalecki AM, Vernon MC, Westman EC.
PMID: 16318637
Nutr Metab (Lond). 2005 Dec 01;2:34. doi: 10.1186/1743-7075-2-34.

BACKGROUND: The low-carbohydrate, ketogenic diet (LCKD) may be effective for improving glycemia and reducing medications in patients with type 2 diabetes.METHODS: From an outpatient clinic, we recruited 28 overweight participants with type 2 diabetes for a 16-week single-arm pilot...

Cite
Yancy WS, Foy M, Chalecki AM, et al. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond). 2005;2:34doi: 10.1186/1743-7075-2-34.
Yancy, W. S., Foy, M., Chalecki, A. M., Vernon, M. C., & Westman, E. C. (2005). A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutrition & metabolism, 234. https://doi.org/10.1186/1743-7075-2-34
Yancy, William S, et al. "A low-carbohydrate, ketogenic diet to treat type 2 diabetes." Nutrition & metabolism vol. 2 (2005): 34. doi: https://doi.org/10.1186/1743-7075-2-34
Yancy WS, Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond). 2005 Dec 01;2:34. doi: 10.1186/1743-7075-2-34. PMID: 16318637; PMCID: PMC1325029.
Copy Download .nbib Format: NLM
A Mo(VI) alkylidyne complex with polyhedral oligomeric silsesquioxane ligands: homogeneous analogue of a silica-supported alkyne metathesis catalyst.

Journal of the American Chemical Society

Cho HM, Weissman H, Wilson SR, Moore JS.
PMID: 17105249
J Am Chem Soc. 2006 Nov 22;128(46):14742-3. doi: 10.1021/ja065101x.

A highly active alkyne metathesis catalyst is realized by replacing the amide ligands of a molybdenum(VI) trisamide alkylidyne complex with silanol groups from incompletely condensed POSS (polyhedral oligomeric silsesquioxane) ligands. This catalyst serves as an effective homogeneous mimic of...

Cite
Cho HM, Weissman H, Wilson SR, et al. A Mo(VI) alkylidyne complex with polyhedral oligomeric silsesquioxane ligands: homogeneous analogue of a silica-supported alkyne metathesis catalyst. J Am Chem Soc. 2006;128(46):14742-3doi: 10.1021/ja065101x.
Cho, H. M., Weissman, H., Wilson, S. R., & Moore, J. S. (2006). A Mo(VI) alkylidyne complex with polyhedral oligomeric silsesquioxane ligands: homogeneous analogue of a silica-supported alkyne metathesis catalyst. Journal of the American Chemical Society, 128(46), 14742-3. https://doi.org/10.1021/ja065101x
Cho, Hyeon Mo, et al. "A Mo(VI) alkylidyne complex with polyhedral oligomeric silsesquioxane ligands: homogeneous analogue of a silica-supported alkyne metathesis catalyst." Journal of the American Chemical Society vol. 128,46 (2006): 14742-3. doi: https://doi.org/10.1021/ja065101x
Cho HM, Weissman H, Wilson SR, Moore JS. A Mo(VI) alkylidyne complex with polyhedral oligomeric silsesquioxane ligands: homogeneous analogue of a silica-supported alkyne metathesis catalyst. J Am Chem Soc. 2006 Nov 22;128(46):14742-3. doi: 10.1021/ja065101x. PMID: 17105249.
Copy Download .nbib Format: NLM
Palladium complexes of perylene diimides: strong fluorescence despite direct attachment of late transition metals to organic dyes.

Inorganic chemistry

Weissman H, Shirman E, Ben-Moshe T, Cohen R, Leitus G, Shimon LJ, Rybtchinski B.
PMID: 17503813
Inorg Chem. 2007 Jun 11;46(12):4790-2. doi: 10.1021/ic700539b. Epub 2007 May 16.

We prepared the first sigma-bonded metal complexes of widely utilized organic dyes, perylene tetracarboxylic acid diimides (PDIs). These 1,7-dipalladium PDI complexes were synthesized by C-Br oxidative addition of 1,7-dibromo-N,N'-dicyclohexyl PDI (Br2PDI) to Pd(0) phosphine complexes bearing triphenylphosphine and bischelating...

Cite
Weissman H, Shirman E, Ben-Moshe T, et al. Palladium complexes of perylene diimides: strong fluorescence despite direct attachment of late transition metals to organic dyes. Inorg Chem. 2007;46(12):4790-2doi: 10.1021/ic700539b.
Weissman, H., Shirman, E., Ben-Moshe, T., Cohen, R., Leitus, G., Shimon, L. J., & Rybtchinski, B. (2007). Palladium complexes of perylene diimides: strong fluorescence despite direct attachment of late transition metals to organic dyes. Inorganic chemistry, 46(12), 4790-2. https://doi.org/10.1021/ic700539b
Weissman, Haim, et al. "Palladium complexes of perylene diimides: strong fluorescence despite direct attachment of late transition metals to organic dyes." Inorganic chemistry vol. 46,12 (2007): 4790-2. doi: https://doi.org/10.1021/ic700539b
Weissman H, Shirman E, Ben-Moshe T, Cohen R, Leitus G, Shimon LJ, Rybtchinski B. Palladium complexes of perylene diimides: strong fluorescence despite direct attachment of late transition metals to organic dyes. Inorg Chem. 2007 Jun 11;46(12):4790-2. doi: 10.1021/ic700539b. Epub 2007 May 16. PMID: 17503813.
Copy Download .nbib Format: NLM
[The 1954 health survey of Stockholm. I. Planning & scope].

Nordisk medicin

FRISK AR, HOLMGREN A, STROM G, WERKO L, WESTMAN C, VIKTORSSON KE.
PMID: 13484037
Nord Med. 1957 Sep 26;58(39):1437-40; discussion 1459-62.

No abstract available.

Cite
FRISK AR, HOLMGREN A, STROM G, et al. Stockholms stads hälsoundersökning 1954. I. Planläggning och omfattning. [The 1954 health survey of Stockholm. I. Planning & scope]. Nord Med. 1957;58(39):1437-40; discussion 1459-62
FRISK, A. R., HOLMGREN, A., STROM, G., WERKO, L., WESTMAN, C., & VIKTORSSON, K. E. (1957). Stockholms stads hälsoundersökning 1954. I. Planläggning och omfattning. [The 1954 health survey of Stockholm. I. Planning & scope]. Nordisk medicin, 58(39), 1437-40; discussion 1459-62.
FRISK, A R, et al. "Stockholms stads hälsoundersökning 1954. I. Planläggning och omfattning." [The 1954 health survey of Stockholm. I. Planning & scope]. Nordisk medicin vol. 58,39 (1957): 1437-40; discussion 1459-62.
FRISK AR, HOLMGREN A, STROM G, WERKO L, WESTMAN C, VIKTORSSON KE. Stockholms stads hälsoundersökning 1954. I. Planläggning och omfattning. [The 1954 health survey of Stockholm. I. Planning & scope]. Nord Med. 1957 Sep 26;58(39):1437-40; discussion 1459-62. Swedish. PMID: 13484037.
Copy Download .nbib Format: NLM
Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation.

ClinicoEconomics and outcomes research : CEOR

Mortaz S, Wessman C, Duncan R, Gray R, Badawi A.
PMID: 22553425
Clinicoecon Outcomes Res. 2012;4:91-7. doi: 10.2147/CEOR.S30547. Epub 2012 Apr 10.

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a major global health problem. An estimated 20%-50% of diabetic subjects in Canada are currently undiagnosed, and around 20%-30% have already developed complications. Screening for high blood glucose levels can identify people...

Cite
Mortaz S, Wessman C, Duncan R, et al. Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation. Clinicoecon Outcomes Res. 2012;4:91-7doi: 10.2147/CEOR.S30547.
Mortaz, S., Wessman, C., Duncan, R., Gray, R., & Badawi, A. (2012). Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation. ClinicoEconomics and outcomes research : CEOR, 491-7. https://doi.org/10.2147/CEOR.S30547
Mortaz, Soroush, et al. "Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation." ClinicoEconomics and outcomes research : CEOR vol. 4 (2012): 91-7. doi: https://doi.org/10.2147/CEOR.S30547
Mortaz S, Wessman C, Duncan R, Gray R, Badawi A. Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation. Clinicoecon Outcomes Res. 2012;4:91-7. doi: 10.2147/CEOR.S30547. Epub 2012 Apr 10. PMID: 22553425; PMCID: PMC3340109.
Copy Download .nbib Format: NLM
Clinical Experience of a Diet Designed to Reduce Aging.

The journal of applied research

Rosedale R, Westman EC, Konhilas JP.
PMID: 20204146
J Appl Res. 2009 Jan 01;9(4):159-165.

OBJECTIVE: Aging is associated with elevated levels of glucose, insulin, and triglycerides. Our objective was to assess the effect of a nutritional program designed to reduce these correlates of aging. DESIGN: This is a retrospective chart review of patients...

Cite
Rosedale R, Westman EC, Konhilas JP. Clinical Experience of a Diet Designed to Reduce Aging. J Appl Res. 2009;9(4):159-165
Rosedale, R., Westman, E. C., & Konhilas, J. P. (2009). Clinical Experience of a Diet Designed to Reduce Aging. The journal of applied research, 9(4), 159-165.
Rosedale, Ron, et al. "Clinical Experience of a Diet Designed to Reduce Aging." The journal of applied research vol. 9,4 (2009): 159-165.
Rosedale R, Westman EC, Konhilas JP. Clinical Experience of a Diet Designed to Reduce Aging. J Appl Res. 2009 Jan 01;9(4):159-165. PMID: 20204146; PMCID: PMC2831640.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 148 entries